📑 Table of Contents

BxPC-3 (BxPC3) is a human pancreatic cancer cell line used in the study of pancreatic adenocarcinomas and treatments thereof.

BxPC-3 cells were derived from a 61-year-old female in 1986, and were confirmed to be tumorigenic in athymic nude mice, with moderate differentiation.[1] The cells produce mucin, and exhibit an epithelial morphology.[2] BxPC-3 cells lack a KRAS mutation,[3] though it is commonly found in pancreatic cancers.[4] BxPC-3 cells, along with JoPaca-1 cells, have high expression of cancer stem cell markers.[5]

BxPC-3 has been used in tumorigenicity studies, pancreatic cancer therapy research, and other biomedical applications. The cells have been additionally studied for their phenotypic and genotypic properties as they can be applied to pancreatic cancer drug development; in particular, BxPC-3 cells have high expression of the angiogenic factors IL-8, VEGF, and PGE2, which can serve as potential drug targets.[6]

See also

edit

References

edit
  1. ^ Tan, Mong H.; etย al. (1986). "Characterization of a New Primary Human Pancreatic Tumor Line". Cancer Investigation. 4 (1): 15โ€“23. doi:10.3109/07357908609039823. PMIDย 3754176.
  2. ^ "ECACC General Cell Collection: BxPC-3". Public Health England. Retrieved 25 June 2018.
  3. ^ "Cellosaurus BxPC-3 (CVCL_0186)". Cellosaurus. Retrieved 25 June 2018.
  4. ^ Berrozpe, G; etย al. (15 July 1994). "Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer". International Journal of Cancer. 58 (2): 185โ€“191. doi:10.1002/ijc.2910580207. PMIDย 8026879. S2CIDย 40118099.
  5. ^ Fredebohm, Johannes; etย al. (12 November 2012). "Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System". PLOS ONE. 7 (11) e48503. Bibcode:2012PLoSO...748503F. doi:10.1371/journal.pone.0048503. PMCย 3495919. PMIDย 23152778.
  6. ^ Deer, Emily; etย al. (May 2010). "Phenotype and Genotype of Pancreatic Cancer Cell Lines". Pancreas. 39 (4): 425โ€“435. doi:10.1097/MPA.0b013e3181c15963. PMCย 2860631. PMIDย 20418756.
edit

๐Ÿ“š Artikel Terkait di Wikipedia

MIA PaCa-2

and augmented drug-delivery methods relying on quantum dots. DU145 PANC-1 BxPC-3 Gradiz, Rui; etย al. (17 February 2016). "MIA PaCa-2 and PANC-1 โ€“ pancreas

PANC-1

calcium-mediated actin reset in response to physiological changes. DU145 BxPC-3 MIA PaCa-2 Lieber, Michael; etย al. (15 May 1975). "Establishment of a continuous

LI-COR Biosciences

potentiated by soy isoflavone genistein, a natural inhibitor of NF-[kappa]B in BxPC-3 pancreatic cancer cell line". Pancreas. 28 (4): 90โ€“95. doi:10

Chromosome 5 open reading frame 15

ฮฒ-catenin gene within BxPC-3 cells is disrupted. This is thought to be a product of reduced cell to cell signaling pathways in BxPC-3 cells when the WNT

Cucurmosin

induces apoptosis of BxPC-3 human pancreatic cancer cells via inactivation of the EGFR signaling pathway". Oncology Reports. 27 (3): 891โ€“897. doi:10.3892/or

Cell culture

Springer International Publishing. pp.ย 41โ€“52. doi:10.1007/978-3-319-07758-1_3. ISBNย 978-3-319-07757-4. Harris AR, Peter L, Bellis J, Baum B, Kabla AJ,

Indocyanine green

been shown to kill human pancreatic cancer cells (MIA PaCa-2, PANC-1, and BxPC-3) in vitro. ICG and an infrared laser have also been used the same way to

Cyclamin

its toxicity against several types of cancer cells: SK-BR-3, HT-29, HepG2/3A, NCI-H1299, BXPC-3, 22RV1 but also on its toxicity against human normal fibroblasts